bivalirudin cipla 250 milligram pdr/conc/soln/inj/inf
cipla (eu) limited - bivalirudin - pdr/conc/soln/inj/inf - 250 milligram - direct thrombin inhibitors
angiox
the medicines company uk ltd - bivalirudin - acute coronary syndrome - antithrombotic agents - angiox is indicated as an anticoagulant in adult patients undergoing percutaneous coronary intervention (pci), including patients with st-segment-elevation myocardial infarction (stemi) undergoing primary pci.angiox is also indicated for the treatment of adult patients with unstable angina / non-st-segment-elevation myocardial infarction (ua / nstemi) planned for urgent or early intervention.angiox should be administered with aspirin and clopidogrel.
angiox 250mg powder for concentrate for solution for infusion vials
the medicines company uk ltd - bivalirudin - powder for solution for infusion - 250mg
bivalirudin 250mg powder for concentrate for solution for infusion vials
accord-uk ltd - bivalirudin - powder for solution for infusion - 250mg
angiomax powder for solution
sandoz canada incorporated - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors
bivalirudin powder for solution
sandoz canada incorporated - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors
bivalirudin for injection powder for solution
fresenius kabi canada ltd - bivalirudin - powder for solution - 250mg - bivalirudin 250mg - direct thrombin inhibitors
bivalirudin 250mg powder for concentrate for solution for infusion vials
reig jofre uk ltd - bivalirudin - powder for solution for infusion - 250mg
bivalirudin accord healthcare 250 mg inj./inf. sol. (pwdr., conc.) i.v. vial
accord healthcare b.v. - bivalirudin 250 mg - powder for concentrate for solution for injection/infusion - 250 mg - bivalirudin 250 mg - bivalirudin
angiox 250 mg powder for concentrate for solution for infusion
the medicines company - bivalirudin - powder for concentrate for solution for infusion - 250 mg